A solid agent carrier body uses micro-scale protrusions to transport pharmaceutical substances via ultrasonic energy.
PCR amplicon vectors eliminate antibiotic resistance genes and endotoxins from plasmid vaccines, enabling rapid manufacturing of safer cancer immunotherapies.
Integrating magnetic retention with acoustic excitation aligns fields, resolving geometric misalignment that reduces drug delivery efficacy.
Linear plasmids stabilize long poly(A) tracts, resolving circular DNA instability and enabling precise IVT mRNA generation.
Ultrasound-triggered decafluoropentane nanodroplets deliver oxygen to hypoxic tissues, overcoming limited penetration in conventional therapies.
Wireless thermal treatment creates controlled micropores in the stratum corneum, resolving power connection constraints while enhancing active agent permeation.
In vivo electroporation delivers PD1 plasmids to tumor tissue, reducing treatment costs by enabling host cells to produce therapeutic proteins endogenously.